Ardelyx Inc
Biotechnology
Healthcare
ARDX
239 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
6.19
52 week high
6.93
high
6.22
52 week low
0.00
low
6.09
growth
0.33 %
previous Close
6.22
P/E ratio
market cap
1.24 B
div yield
0
usd
Jun 2025
qoq
revenue
97.66 M
31.77 %
net incoming
-19.08 M
53.63 %
eps
0.00 %
52.94 %
eps surprise
34.37 %
net profit margin
-19.54 %
35.00 %
operating incoming
-14.40 M
60.40 %
net change in cash
59.24 M
273.59 %
cash on hand
90.05 M
192.28 %
cost of revenue
12.40 M
24.49 %
top top